Creative Planning Has $1.38 Million Stock Holdings in American Healthcare REIT, Inc. $AHR

Creative Planning increased its position in American Healthcare REIT, Inc. (NYSE:AHRFree Report) by 4.5% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 37,467 shares of the company’s stock after purchasing an additional 1,628 shares during the quarter. Creative Planning’s holdings in American Healthcare REIT were worth $1,377,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of AHR. Physician Wealth Advisors Inc. acquired a new position in American Healthcare REIT during the second quarter worth approximately $34,000. Avalon Trust Co acquired a new stake in shares of American Healthcare REIT in the first quarter valued at approximately $36,000. GAMMA Investing LLC boosted its stake in shares of American Healthcare REIT by 22.1% during the 2nd quarter. GAMMA Investing LLC now owns 1,716 shares of the company’s stock worth $63,000 after acquiring an additional 311 shares during the period. Grove Bank & Trust acquired a new position in shares of American Healthcare REIT during the 2nd quarter worth approximately $130,000. Finally, Franchise Capital Ltd raised its stake in American Healthcare REIT by 76.8% in the 2nd quarter. Franchise Capital Ltd now owns 4,375 shares of the company’s stock valued at $161,000 after acquiring an additional 1,900 shares during the period. Institutional investors own 16.68% of the company’s stock.

American Healthcare REIT Stock Performance

Shares of NYSE:AHR opened at $50.78 on Friday. American Healthcare REIT, Inc. has a 12-month low of $26.40 and a 12-month high of $50.91. The company’s 50 day moving average price is $44.92 and its two-hundred day moving average price is $40.54. The firm has a market cap of $8.98 billion, a PE ratio of 362.71, a PEG ratio of 2.10 and a beta of 0.98. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.37.

American Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 17th. Shareholders of record on Tuesday, September 30th were paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date was Tuesday, September 30th. American Healthcare REIT’s dividend payout ratio (DPR) is 714.29%.

Insider Buying and Selling at American Healthcare REIT

In other news, EVP Mark E. Foster sold 3,850 shares of the company’s stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $41.89, for a total transaction of $161,276.50. Following the completion of the sale, the executive vice president directly owned 59,100 shares in the company, valued at approximately $2,475,699. This represents a 6.12% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Jeffrey T. Hanson sold 20,010 shares of the stock in a transaction on Monday, November 10th. The stock was sold at an average price of $49.68, for a total value of $994,096.80. Following the sale, the director directly owned 21,798 shares in the company, valued at approximately $1,082,924.64. This trade represents a 47.86% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 25,360 shares of company stock valued at $1,229,398 over the last ninety days. Insiders own 0.92% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on AHR. Citigroup lifted their price objective on shares of American Healthcare REIT from $45.00 to $52.00 and gave the stock a “neutral” rating in a research report on Friday, November 21st. Royal Bank Of Canada lifted their target price on shares of American Healthcare REIT from $45.00 to $54.00 and gave the stock an “outperform” rating in a report on Wednesday, November 12th. Truist Financial upped their price target on shares of American Healthcare REIT from $46.00 to $53.00 and gave the company a “buy” rating in a research note on Wednesday. Zacks Research upgraded shares of American Healthcare REIT from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 17th. Finally, JMP Securities boosted their price objective on American Healthcare REIT from $45.00 to $50.00 and gave the stock a “market outperform” rating in a report on Friday, October 17th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $51.64.

Get Our Latest Report on AHR

About American Healthcare REIT

(Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

See Also

Institutional Ownership by Quarter for American Healthcare REIT (NYSE:AHR)

Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.